Stem cell scientists: Can you wait light years for new detection technology?Stem cell scientists: Can you wait light years for new detection technology?BioAstral would appreciate your feedback on how you’re are imaging and tracking your cells. The goal of the survey is to quantify which of the benefits of BioAstral fluorescence detector technology could accelerate your research activities. You will be the given the opportunity to receive the anonymised results of this survey by providing your contact information and email permission. Thank you in advance for your feedback.
The BioAstral fluorescence detector technology, based on cryogenic STJs, is unique in detecting both the arrival of a photon and the colour of each photon. This heralds a long-awaited revolution in a technique that now dominates the readout of biomedical research assays.
Click here to take the survey.The future of biology is the detection of light
Biomedical researchers the world over use fluorescent probes to discover what is going on inside cells and how they interact with the outside world. Drug discovery and medical diagnostics exploit fluorescent assays. Genomics researchers use fluorescent probes to answer questions such as: "Which genes are being expressed?" or "How are genes controlled?"
To answer the toughest questions, researchers need:
Improved quantification of light
More probes assayed simultaneously
Greater throughput and sensitivity
Higher background discrimination and wide bandwidth
Accurate measurement of arrival time of photons
These are all features delivered by our BioAstral hyperspectral photon detection technology.
The BioAstral technology provides a unique solution that is based on fundamentally different science from:
19th century film or
20th century technologies such as CCD, CMOS, APD or PMTs.
BioAstral has been selected to present at the ESA Investment forum
You are on the BioAstral Homepage. If navigation panes are not visible please click here - www.bioastral.com